These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9449637)

  • 41. Calcium-dependent control of corticotropin release in rat anterior pituitary cell cultures.
    Abou-Samra AB; Catt KJ; Aguilera G
    Endocrinology; 1987 Sep; 121(3):965-71. PubMed ID: 2441983
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists.
    Rivier J; Gulyas J; Kirby D; Low W; Perrin MH; Kunitake K; DiGruccio M; Vaughan J; Reubi JC; Waser B; Koerber SC; Martinez V; Wang L; Taché Y; Vale W
    J Med Chem; 2002 Oct; 45(21):4737-47. PubMed ID: 12361401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective impairment of corticotropin-releasing factor1 (CRF1) receptor-mediated function using CRF coupled to saporin.
    Maciejewski-Lenoir D; Heinrichs SC; Liu XJ; Ling N; Tucker A; Xie Q; Lappi DA; Grigoriadis DE
    Endocrinology; 2000 Feb; 141(2):498-504. PubMed ID: 10650928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Continuous and pulsatile infusions of luteinizing hormone have identical effects on steroidogenic capacity and sensitivity of Leydig cells in rats passively immunized against gonadotropin-releasing hormone.
    Gibson-Berry KL; Chase DJ
    Endocrinology; 1990 Jun; 126(6):3107-15. PubMed ID: 1693567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The highly selective CRF(2) receptor antagonist K41498 binds to presynaptic CRF(2) receptors in rat brain.
    Lawrence AJ; Krstew EV; Dautzenberg FM; Rühmann A
    Br J Pharmacol; 2002 Jul; 136(6):896-904. PubMed ID: 12110614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence that corticotropin-releasing factor receptor type 1 couples to Gs- and Gi-proteins through different conformations of its J-domain.
    Berger H; Heinrich N; Wietfeld D; Bienert M; Beyermann M
    Br J Pharmacol; 2006 Dec; 149(7):942-7. PubMed ID: 17057757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding.
    Wille S; Sydow S; Palchaudhuri MR; Spiess J; Dautzenberg FM
    J Neurochem; 1999 Jan; 72(1):388-95. PubMed ID: 9886092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of tumor necrosis factor-alpha in the regulation of mouse Leydig cell steroidogenesis.
    Xiong Y; Hales DB
    Endocrinology; 1993 Jun; 132(6):2438-44. PubMed ID: 8504748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pituitary adenylate cyclase activating polypeptide stimulates rat Leydig cell steroidogenesis through a novel transduction pathway.
    Rossato M; Nogara A; Gottardello F; Bordon P; Foresta C
    Endocrinology; 1997 Aug; 138(8):3228-35. PubMed ID: 9231772
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Achieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domain.
    Beyermann M; Heinrich N; Fechner K; Furkert J; Zhang W; Kraetke O; Bienert M; Berger H
    Br J Pharmacol; 2007 Jul; 151(6):851-9. PubMed ID: 17533422
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Roles of intracellular and extracellular calcium in the kinetic profile of adrenocorticotropin secretion by perifused rat anterior pituitary cells. I. Corticotropin-releasing factor stimulation.
    Won JG; Orth DN
    Endocrinology; 1990 Feb; 126(2):849-57. PubMed ID: 2153529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Corticotropin-releasing factor: an antireproductive hormone of the testis.
    Dufau ML; Tinajero JC; Fabbri A
    FASEB J; 1993 Feb; 7(2):299-307. PubMed ID: 8382638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Importance of the paraventricular nucleus of the hypothalamus as a component of a neural pathway between the brain and the testes that modulates testosterone secretion independently of the pituitary.
    Selvage DJ; Rivier C
    Endocrinology; 2003 Feb; 144(2):594-8. PubMed ID: 12538621
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of two corticotropin-releasing factor receptors from Xenopus laevis with high ligand selectivity: unusual pharmacology of the type 1 receptor.
    Dautzenberg FM; Dietrich K; Palchaudhuri MR; Spiess J
    J Neurochem; 1997 Oct; 69(4):1640-9. PubMed ID: 9326293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The alternatively spliced type II corticotropin-releasing factor receptor, stably expressed in LLCPK-1 cells, is not well coupled to the G protein(s).
    Nabhan C; Xiong Y; Xie LY; Abou-Samra AB
    Biochem Biophys Res Commun; 1995 Jul; 212(3):1015-21. PubMed ID: 7626087
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A role for a helical connector between two receptor binding sites of a long-chain peptide hormone.
    Beyermann M; Rothemund S; Heinrich N; Fechner K; Furkert J; Dathe M; Winter R; Krause E; Bienert M
    J Biol Chem; 2000 Feb; 275(8):5702-9. PubMed ID: 10681555
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urocortin 1 inhibits rat leydig cell function.
    Rivier CL
    Endocrinology; 2008 Dec; 149(12):6425-32. PubMed ID: 18719027
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor.
    Gulyas J; Rivier C; Perrin M; Koerber SC; Sutton S; Corrigan A; Lahrichi SL; Craig AG; Vale W; Rivier J
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10575-9. PubMed ID: 7479843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional corticotropin-releasing factor receptors in human neuroblastoma cells.
    Dieterich KD; DeSouza EB
    Brain Res; 1996 Sep; 733(1):113-8. PubMed ID: 8891255
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site.
    Dautzenberg FM; Wille S; Lohmann R; Spiess J
    Proc Natl Acad Sci U S A; 1998 Apr; 95(9):4941-6. PubMed ID: 9560207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.